The use of substituted tetracyclic imidazole derivatives as anti-histaminics

The invention concerns the use of an H1- and/or H2-histamine receptor antagonist for the reduction of intracranial pressure (ICP), in particular for the prevention and treatment of elevated intracranial pressure and/or secondary ischaemia, in particular caused by brain injury, more in particular cau...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	BARTOLOME-NEBREDA JOSE MANUEL, VAN REEMPTS JOZEF LEO HENRI, LEENAERTS JOSEPH ELISABETH, ALCAZAR-VACA MANUEL JESUS, VAN ROSSEM KOENRAAD ARTHUR, FERNANDEZ-GADEA FRANCISCO JAVIER, MARTINEZ-JIMENEZ PEDRO, GOMEZ-SANCHEZ ANTONIO, TEGTMEIER FRANK, JANSSENS FRANS EDUARD
Format:	Patent
Sprache:	eng ; hun
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!